Hello doctor and thanks for your time here,
Do you know anything about the 2nd study within the Telaprevir phase 3 trial. This 2nd study will enroll around 400-500 participants starting around Sept. The only info I have is from a press release this past January, it says that it will evaluate with 48 weeks of tx. I received a call from my docs office and the nurse said they will be doing the 2nd study. She said it may be a month before she has the full protocol from Vertex but from what she already has it looks like there will be two arms treating 24 & 48 weeks not just 48 like the original plan? Also it sounds like everyone will receive the study drug? Can you please clarify this if you have any information. Thank you